Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Youri Hoogstrate

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Neuro-Oncology Advances|July 10, 2020
EGFR mutations are associated with response to depatux-m in combination with temozolomide and result in a receptor that is hypersensitive to ligandYouri Hoogstrate, Wies Vallentgoed, Johan M Kros, et al.
International Journal of Cancer|August 15, 2019
Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progressionMalgorzata A Komor, Meike de Wit, Jose van den Berg, et al.
Cancer Research|January 15, 2016
Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB TrialLale Erdem-Eraslan, Martin J van den Bent, Youri Hoogstrate, et al.
Science Advances|June 30, 2020
Guide-free Cas9 from pathogenic <i>Campylobacter jejuni</i> bacteria causes severe damage to DNAChinmoy Saha, Prarthana Mohanraju, Andrew Stubbs, et al.
F1000Research|November 11, 2017
Systematically linking tranSMART, Galaxy and EGA for reusing human translational research dataChao Zhang, Jochem Bijlard, Christine Staiger, et al.
Neuro-Oncology Advances|November 29, 2023
Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohortKarin A van Garderen, Wies R Vallentgoed, Anna Lavrova, et al.
Communications Biology|April 9, 2022
CRISPRs in the human genome are differentially expressed between malignant and normal adjacent to tumor tissueJob van Riet, Chinmoy Saha, Nikolaos Strepis, et al.
Cell Systems|June 29, 2018
Community-Driven Data Analysis Training for BiologyBérénice Batut, Saskia Hiltemann, Andrea Bagnacani, et al.
Cancer Cell|March 10, 2023
Transcriptome analysis reveals tumor microenvironment changes in glioblastomaYouri Hoogstrate, Kaspar Draaisma, Santoesha A Ghisai, et al.
Cell Reports. Medicine|March 18, 2026
TET CpG sequence-context-specific DNA demethylation shapes progression of IDH-mutant gliomasYouri Hoogstrate, Santoesha A Ghisai, Levi van Hijfte, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Neuro-Oncology Advances|July 10, 2020
EGFR mutations are associated with response to depatux-m in combination with temozolomide and result in a receptor that is hypersensitive to ligandYouri Hoogstrate, Wies Vallentgoed, Johan M Kros, et al.
International Journal of Cancer|August 15, 2019
Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progressionMalgorzata A Komor, Meike de Wit, Jose van den Berg, et al.
Cancer Research|January 15, 2016
Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB TrialLale Erdem-Eraslan, Martin J van den Bent, Youri Hoogstrate, et al.
Science Advances|June 30, 2020
Guide-free Cas9 from pathogenic <i>Campylobacter jejuni</i> bacteria causes severe damage to DNAChinmoy Saha, Prarthana Mohanraju, Andrew Stubbs, et al.
F1000Research|November 11, 2017
Systematically linking tranSMART, Galaxy and EGA for reusing human translational research dataChao Zhang, Jochem Bijlard, Christine Staiger, et al.
Neuro-Oncology Advances|November 29, 2023
Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohortKarin A van Garderen, Wies R Vallentgoed, Anna Lavrova, et al.
Communications Biology|April 9, 2022
CRISPRs in the human genome are differentially expressed between malignant and normal adjacent to tumor tissueJob van Riet, Chinmoy Saha, Nikolaos Strepis, et al.
Cell Systems|June 29, 2018
Community-Driven Data Analysis Training for BiologyBérénice Batut, Saskia Hiltemann, Andrea Bagnacani, et al.
Cancer Cell|March 10, 2023
Transcriptome analysis reveals tumor microenvironment changes in glioblastomaYouri Hoogstrate, Kaspar Draaisma, Santoesha A Ghisai, et al.
Cell Reports. Medicine|March 18, 2026
TET CpG sequence-context-specific DNA demethylation shapes progression of IDH-mutant gliomasYouri Hoogstrate, Santoesha A Ghisai, Levi van Hijfte, et al.
Pageof 4